Compare ARWR & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARWR | UEC |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.5B |
| IPO Year | 1993 | N/A |
| Metric | ARWR | UEC |
|---|---|---|
| Price | $58.23 | $11.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $55.50 | $15.80 |
| AVG Volume (30 Days) | 2.5M | ★ 9.3M |
| Earning Date | 11-25-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $829,448,000.00 | $66,837,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $103.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 23258.15 | ★ 29737.94 |
| 52 Week Low | $9.57 | $3.85 |
| 52 Week High | $59.15 | $17.80 |
| Indicator | ARWR | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 74.49 | 44.57 |
| Support Level | $37.06 | $10.39 |
| Resistance Level | $59.15 | $12.47 |
| Average True Range (ATR) | 3.92 | 0.83 |
| MACD | 1.64 | 0.06 |
| Stochastic Oscillator | 90.86 | 67.74 |
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.